Breast cancer patient-derived organoids for the investigation of patient-specific tumour evolution
Serena Mazzucchelli(University of Milan), Fabio Corsi(Istituti Clinici Scientifici Maugeri), Ingrid Cifola(Institute of Biomedical Technologies), Lorena Signati(University of Milan), Laura Villani(Istituti Clinici Scientifici Maugeri), Paride Pelucchi(Institute of Biomedical Technologies), Patrizia Gasparini(Fondazione IRCCS Istituto Nazionale dei Tumori), Eleonora Mangano(Institute of Biomedical Technologies), Alma Franceschini(Fondazione IRCCS Istituto Nazionale dei Tumori), Serenella M. Pupa(Tumori Foundation), Lorenzo Castagnoli(Fondazione IRCCS Istituto Nazionale dei Tumori), Stephana Carelli(ASST Fatebenefratelli Sacco), Tania Camboni(National Academies of Sciences, Engineering, and Medicine), Barbara Tagliaferri(Istituti Clinici Scientifici Maugeri), Letizia Messa(Politecnico di Milano), Arianna Bonizzi, Clarissa Consolandi(Construction Technologies Institute), Marco Severgnini(Construction Technologies Institute), Cristina Cereda(University of Milan)
Cited by 11
Related Papers
Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
|American Journal of Medical Genetics Part A|2015|617
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
|Nature Genetics|2021|567
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
|The Lancet Neurology|2013|441
Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism
|Movement Disorders|2018|390